Ketamine Hydrochloride for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jan 2018: Trial registered, NCT03410446
  2. 16 Jul 2018: Trial started, NCT03410446

The trials

NCT03410446: Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

State
Completed
Phase
Phase 2
People
22 taking part
Started
16 Jul 2018
Primary completion
27 Nov 2021
Arms
Ketamine
Results
None posted
  1. 25 Jan 2018: Trial registered
  2. 16 Jul 2018: Trial started
  3. 27 Nov 2021: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Ketalar, Ketaset, Ketamine hydrochloride infusion, Vetalar.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.